| Optimizing oral targeted anticancer therapies study for patients with solid cancer: protocol for a randomized controlled medication adherence program along with systematic … C Bandiera, E Cardoso, I Locatelli, A Digklia, K Zaman, A Diciolla, ... JMIR Research Protocols 10 (6), e30090, 2021 | 13 | 2021 |
| Swiss priority setting on implementing medication adherence interventions as part of the European ENABLE COST action C Bandiera, J Ribaut, AL Dima, SS Allemann, K Molesworth, K Kalumiya, ... International journal of public health 67, 1605204, 2022 | 7 | 2022 |
| Interprofessional medication adherence program for patients with diabetic kidney disease: protocol for a randomized controlled and qualitative study (PANDIA-IRIS) C Bandiera, J Dotta-Celio, I Locatelli, D Nobre, G Wuerzner, M Pruijm, ... JMIR Research Protocols 10 (3), e25966, 2021 | 7 | 2021 |
| Adherence to the CDK 4/6 inhibitor palbociclib and omission of dose management supported by pharmacometric modelling as part of the OpTAT study C Bandiera, I Locatelli, P Courlet, E Cardoso, K Zaman, A Stravodimou, ... Cancers 15 (1), 316, 2023 | 4 | 2023 |
| Understanding reasons and factors for participation and non-participation to a medication adherence program for patients with diabetic kidney disease in Switzerland: a mixed … C Bandiera, L Lam, I Locatelli, J Dotta-Celio, D Duarte, G Wuerzner, ... Diabetology & metabolic syndrome 14 (1), 140, 2022 | 4 | 2022 |
| Population pharmacokinetics of palbociclib and its correlation with clinical efficacy and safety in patients with advanced breast cancer P Courlet, E Cardoso, C Bandiera, A Stravodimou, JP Zurcher, H Chtioui, ... Pharmaceutics 14 (7), 1317, 2022 | 4 | 2022 |
| Medication adherence and physician-pharmacist collaboration. Focus on the patient with diabetic nephropathy M Schneider, C Bandiera, J Dotta-Celio, A Zanchi Revue Medicale Suisse 16 (697), 1210-1213, 2020 | 3 | 2020 |
| Medication adherence evaluated through electronic monitors during the 2020 COVID-19 pandemic lockdown in Switzerland: a longitudinal analysis C Bandiera, J Pasquier, I Locatelli, A Niquille, G Wuerzner, J Dotta-Celio, ... Patient preference and adherence, 2313-2320, 2022 | 2 | 2022 |
| The differential impact of a 6-versus 12-month pharmacist-led interprofessional medication adherence program on medication adherence in patients with diabetic … C Bandiera, J Dotta-Celio, I Locatelli, D Nobre, G Wuerzner, M Pruijm, ... Frontiers in Pharmacology 15, 1294436, 2024 | 1 | 2024 |
| Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland C Bandiera, X Skrabal Ross, E Cardoso, D Wagner, C Csajka, I Olver, ... Supportive Care in Cancer, 1-5, 2022 | 1 | 2022 |
| La luminothérapie, traitement de premier choix C Bandiera, D Carli, J Berger pharmaJournal, 2019 | 1 | 2019 |
| Drivers of citations in social pharmacy and practice research articles N Shcherbakova, S Desselle, C Bandiera, J Canedo, AV Law, P Aslani Research in Social and Administrative Pharmacy 20 (7), 590-596, 2024 | | 2024 |
| Exploring research and education opportunities in digital health for pharmacy, medicine and other health disciplines: Insights from a multinational workshop E Obarcanin, P Aslani, AHY Ho, C Bandiera, M Baysari, I Bojic, ... Exploratory Research in Clinical and Social Pharmacy, 100469, 2024 | | 2024 |
| Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study A Ravix, C Bandiera, E Cardoso, A Lata-Pedreira, H Chtioui, ... Cancers 16 (12), 2193, 2024 | | 2024 |
| A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial C Bandiera, E Cardoso, I Locatelli, K Zaman, A Diciolla, A Digklia, ... Plos one 19 (6), e0304573, 2024 | | 2024 |
| Using a Semiautomated Procedure (CleanADHdata. R Script) to Clean Electronic Adherence Monitoring Data: Tutorial C Bandiera, J Pasquier, I Locatelli, MP Schneider JMIR Formative Research 8 (1), e51013, 2024 | | 2024 |
| CN42 A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial C Bandiera, E Cardoso, I Locatelli, K Zaman, A Diciolla, A Digklia, ... Annals of Oncology 34, S1237, 2023 | | 2023 |
| Diabetic nephropathy: Interprofessional support of medication adherence C Bandiera, D Duarte, J Dotta-Celio, A Zanchi, MP Schneider Revue medicale suisse 19 (829), 1085-1089, 2023 | | 2023 |
| AN INTERPROFESSIONAL INTERVENTION TO SUPPORT ADHERENCE TO COMPLEX AND POLYPHARMACY TREATMENTS IN PATIENTS WITH SOLID CANCER AND PATIENTS WITH DIABETIC KIDNEY DISEASE C BANDIERA Université de Genève, 2023 | | 2023 |
| Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study. Cancers 2023, 15, 316 C Bandiera, I Locatelli, P Courlet, E Cardoso, K Zaman, A Stravodimou, ... | | 2023 |
Marie SchneiderProfessor of medication adherence and interprofessionality在 unige.ch 的电子邮件经过验证
